Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone ("VCD-Lite") in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma
| Image |  |
|---|---|
| Description | scientific article published on 27 February 2017 |
| Author/s |
author: Gwynn D Long |
| Publication date | February 27, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |